Results 191 to 200 of about 694,820 (288)

Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

open access: yesArteriosclerosis and Thrombosis A Journal of Vascular Biology, 1992
J. R. Patsch   +7 more
semanticscholar   +1 more source

A Metabolomic Signature Predicts Gout Flare Clinical Outcome Associated With Colchicine Prophylaxis

open access: yesArthritis &Rheumatology, EarlyView.
Objective This study investigated that serum metabolomics, before urate‐lowering therapy (ULT) initiation, could serve as a biomarker for responsiveness to colchicine prophylaxis in patients with gout commencing treat‐to‐target ULT. Methods We studied a multicenter prospective cohort (n = 409) initiating treat‐to‐target ULT plus colchicine prophylaxis.
Wenyan Sun   +13 more
wiley   +1 more source

Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis

open access: yesHepatology, 2007
K. Yamaguchi   +9 more
semanticscholar   +1 more source

5‐Methylcytosine Analysis of miRNAs in Minimal Change Disease

open access: yesBiotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Minimal change disease (MCD) is a glomerular disorder, which is the most common cause of nephrotic syndrome in children. Additionally, the prevalence of MCD in adults has been increasing in recent years. During protein synthesis, noncoding RNAs can be regulated through a variety of modifications, which helps preserve biological diversity and ...
Huiyi Zeng   +14 more
wiley   +1 more source

ApoJ regulates endothelial lipase activity and stability. [PDF]

open access: yesProtein Sci
Jean-Baptiste UL   +5 more
europepmc   +1 more source

PCSK9 Induces CD36 Degradation and Affects Long-Chain Fatty Acid Uptake and Triglyceride Metabolism in Adipocytes and in Mouse Liver

open access: yesArteriosclerosis, Thrombosis and Vascular Biology, 2015
Annie Demers   +6 more
semanticscholar   +1 more source

Long‐term impact of Elexacaftor/Tezacaftor/ivacaftor on pulmonary, nutritional and metabolic outcomes in homozygous F508del cystic fibrosis patients: A real‐world cohort study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Elexacaftor/tezacaftor/ivacaftor (ETI) has markedly improved cystic fibrosis (CF) outcomes. However, its long‐term impact on nutrition, metabolism and liver health remains underexplored. We assessed 30‐month changes in pulmonary, nutritional, metabolic and inflammatory markers in people with CF (PwCF) homozygous for F508del.
Nicola Perrotta   +5 more
wiley   +1 more source

Comparison of the predictive power of novel insulin resistance, lipid metabolism and obesity indices for the risk of developing dyslipidaemia in adults. [PDF]

open access: yesBMC Endocr Disord
Liang Y   +18 more
europepmc   +1 more source

Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids

open access: yesProceedings of the National Academy of Sciences of the United States of America, 2015
D. Vatner   +11 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy